medicinesaustralia.com.au Medicines Australia

medicinesaustralia.com.au
Title: Medicines Australia
Keywords:
Description: Medicines Australia Skip to content Skip to menu Contact Follow Us Member’s Area Toggle navigation Medicines Australia About Us Our Role Secretariat Our Members Corporate Policy Membership Information
medicinesaustralia.com.au is ranked 2426067 in the world (amongst the 40 million domains). A low-numbered rank means that this website gets lots of visitors. This site is relatively popular among users in the united states. It gets 50% of its traffic from the united states .This site is estimated to be worth $5,863. This site has a low Pagerank(0/10). It has 1 backlinks. medicinesaustralia.com.au has 43% seo score.

medicinesaustralia.com.au Information

Website / Domain: medicinesaustralia.com.au
Website IP Address: 202.129.142.138
Domain DNS Server: brigh.twoplums.com.au,mutley.twoplums.com.au

medicinesaustralia.com.au Rank

Alexa Rank: 2426067
Google Page Rank: 0/10 (Google Pagerank Has Been Closed)

medicinesaustralia.com.au Traffic & Earnings

Purchase/Sale Value: $5,863
Daily Revenue: $16
Monthly Revenue $481
Yearly Revenue: $5,863
Daily Unique Visitors 1,478
Monthly Unique Visitors: 44,340
Yearly Unique Visitors: 539,470

medicinesaustralia.com.au WebSite Httpheader

StatusCode 200
Content-Type text/html; charset=UTF-8
Date Sun, 31 Jul 2016 02:00:29 GMT

medicinesaustralia.com.au Keywords accounting

Keyword Count Percentage

medicinesaustralia.com.au Traffic Sources Chart

medicinesaustralia.com.au Similar Website

Domain Site Title

medicinesaustralia.com.au Alexa Rank History Chart

medicinesaustralia.com.au aleax

medicinesaustralia.com.au Html To Plain Text

Medicines Australia Skip to content Skip to menu Contact Follow Us Member’s Area Toggle navigation Medicines Australia About Us Our Role Secretariat Our Members Corporate Policy Membership Information Positions Vacant Board Contact Legal Statements Member logon request Policy AMWG Clinical Trials Clinical Trials Action Group Clinical Trials Research Agreements Indemnity & Compensation Guidelines Oncology Industry Taskforce Publications COMPARE Facts Book Occasional Papers Reports Submissions Media and Events Events Archived Events Features Media Releases Pat Clear Award About Pat Clear Recipients of the Award Speeches Code About the Code Current Edition Archived Codes of Conduct Transparency Working Group How to Make a Complaint Code of Conduct Review 2013/2014 Code Review Panel 2013/2014 Submissions Archived Code of Conduct Reviews Committee Meeting Dates Committee Membership Code of Conduct Reports Annual Reports General Public Activities Quarterly Reports Transparency Reporting Advisory Board Reports Central Database Working Group Educational Event Reports Health Consumer Organisation Support Reports Healthcare Professional Consultant Reports Glossary Training Code Workshops Continuing Education Program (CEP) Help Community Working Together Guide About the Special Purpose Fund Purple Truck Shalom Gamarada Baker IDI Thumbs Up! Collaboration for Health in PNG Search Medicines Australia Annual Report 2014-2015 Read more Working Together Guide A framework outlining how industry can engage with consumer groups Read More Comparison of Access and Reimbursement Environments Read more Code of Conduct Edition 18 In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry About Us Papers, Reports & Submissions Publications Agreements, Indemnity & Compensation Guidelines Clinical Trials Awards, Speeches & Media Releases Media & Events Member company lounge Member's Area Medicines Australia supports world hepatitis day 2016 On the occasion of World Hepatitis Day, Medicines Australia calls for greater awareness about hepatitis and the ongoing need for disease prevention, testing and treatment. The day is particularly significant in Australia as it marks the year innovative therapies were introduced to the Pharmaceutical Benefits Scheme (PBS), achieving major advances in treatment for Hepatitis C,… View article· Thursday, 28 July 2016 Shorten Shadow Ministry Medicines Australia would like to congratulate the Hon. Bill Shorten as leader of the Opposition for the appointment of his Shadow Ministry following the Federal Election. The decision to re-appoint the Hon. Catherine King MP as the Shadow Minister for Health is a welcome decision and Medicines Australia congratulates Ms King for continuing in this… View article· Sunday, 24 July 2016 Turnbull Government Ministry Medicines Australia would like to acknowledge the appointment of the Turnbull Government Ministry following the Federal Election. With the recent confirmation that Prime Minister Turnbull will lead a majority government and today’s appointment of the Ministry, Medicines Australia looks forward to the resumption of Parliamentary business and policy development which is in the interests of… View article· Monday, 18 July 2016 AusBiotech CEO Medicines Australia would like to acknowledge the great contribution made by Dr Anna Lavelle to Australia’s biotechnology industry as she steps down from being the CEO of AusBiotech. Throughout her eleven years at the helm, Dr Lavelle has been a tremendous advocate for her members and the broader life science sector. Medicines Australia has had… View article· Friday, 15 July 2016 World No Tobacco Day World No Tobacco Day aims to draw attention to the harmful health effects of smoking. Every year, smoking kills around 15,000 Australians according to the Australian Institute of Health and Welfare. Australia already has some of the toughest smoking regulations in the world, and was the first country in the world to pioneer plain tobacco… View article· Tuesday, 31 May 2016 International Clinical Trials Day Media release Today marks international Clinical Trials Day. It is a time to recognise the contribution clinical trials make to the global efforts to find discover and develop the latest breakthrough medicines and vaccines, as well as celebrating some remarkable advances in Australian medical science. Medicines Australia Chairman, MrWes Cook, said Medicines Australia members conduct around 600-700… View article· Friday, 20 May 2016 Promise to reduce barriers to Clinical Trials will benefit patients The Federal Government’s election commitment to better coordinate clinical trials is welcome news for patients, researchers and innovative medicine companies. Medicines Australia members conduct around 600-700 clinical trials nationally each year in partnership with hospitals, universities and other research institutions. These clinical trials provide Australian patients with early access to the latest potential breakthroughs in… View article· Friday, 20 May 2016 Federal Budget 2016 – Commitment to the PBS The innovative medicines industry acknowledges the Australian Government’s commitment to maintaining funding levels within the Federal Budget for the Pharmaceutical Benefits Scheme (PBS). The PBS is designed to ensure that Australian patients receive timely access to innovative medicines. “We believe tonight’s budget provides predictability in PBS arrangements, improvements to registration processes for new medicines coupled… View article· Tuesday, 3 May 2016 Productivity Commission Draft Report on Intellectual Property Arrangements Medicines Australia notes the release of the draft report from the Productivity Commission concerning Australia’s Intellectual Property (IP) arrangements. While the 400 page draft has only just been made available, we do have a number of concerns with the interim-findings which we believe may inadvertently lead to public misunderstanding of patents and IP as it… View article· Friday, 29 April 2016 World Intellectual Property Day 2016 Medicines Australia acknowledges World Intellectual Property Day, an international initiative celebrating the role intellectual property plays in stimulating innovation. Medicines Australia represents the research-based innovative medicines industry in Australia. Our members invest more than $1 billion every year in Australian-based research and development such as clinical trials and partnerships with Australian Universities, Biotechs and research… View article· Wednesday, 27 April 2016 More Media Releases Sign up for updates Sign up for email updates to keep on top of Medicines Australia developments. Email * Sign up Medicines Australia Blog July 2015 World Cancer Day 2015 February 2015 In a tough global marketplace, focus on competitiveness is key Social Medicines Australia @MedicinesAus Medicines Australia supports world hepatitis day 2016 https://t.co/CVhjPOhnoL Medicines Australia @MedicinesAus Shorten Shadow Ministry https://t.co/y95StMxm7k Medicines Australia @MedicinesAus Turnbull Government Ministry https://t.co/emi5YxJ18B Medicines Australia @MedicinesAus Congrats @GregHuntMP on appointment as Minister for Industry, Innovation & Science. Crucial to Aust. future jobs, economy and health! Medicines Australia @MedicinesAus Congratulations Health Minister @sussanley. MA looks 4wd to working together on faster medicines access and clinical trial reform. Medicines Australia @MedicinesAus AusBiotech CEO https://t.co/DfvLKi8LVX Medicines Australia @MedicinesAus Attn. Aust healthcare workers: check @sanofipasteur Vaxigrants 4 x $25k grants to tackle immunisation uptake, visit https://t.co/rRIZoDsmj8 Medicines Australia @MedicinesAus Congratulations @CSL - an example of the potential for biomedical science and advanced manufacturing in Australia. https://t.co/elbnNI3a7K CSL @CSL RT @CSL: Congratulations to our chief scientific officer Andrew Cuthbertson who received an Officer of the Order of Australia https://t.co/… Medicines Australia @MedicinesAus Interesting discussion on future of Advanced #Manufacturing in Oz @ceda_news. Local talent, right policies R crucial https://t.co/v2MYT6BQ0S Medicines Australia @MedicinesAus World No Tobacco Day https://t.co/8uqcCwcWsj Medicines Australia @MedicinesAus Great initiative by @GSK_AU helping Australia's extraordinary talent in science and medical #research https://t.co/urxHdnAAKb Medicines Australia @MedicinesAus Coalition's plan to help fight rare teen cancer is welcome news for both innovative medicine manufacturers and patients #auspol Footer elements Copyright Disclaimer Privacy Policy Sitemap Contact us Phone: +61 2 6122 8500 Fax: +61 2 6122 8555 Postal address Medicines Australia Level 1, 16 Napier Close Deakin, ACT AUSTRALIA 2600 ? Copyright Medicines Australia ABN 23 126 990 001

medicinesaustralia.com.au Whois

Domain Name: MEDICINESAUSTRALIA.COM.AU